Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77.6M
-
Number of holders
-
263
-
Total shares
-
74M
-
Shares change
-
-3.01M
-
Total reported value, excl. options
-
$4.75B
-
Value change
-
-$196M
-
Put/Call ratio
-
0
-
Number of buys
-
130
-
Number of sells
-
-110
-
Price
-
$64.26
Significant Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q1 2022
264 filings reported holding IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock as of Q1 2022.
INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 263 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74M shares
of 77.6M outstanding shares and own 95.36% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.4M shares), Capital Research Global Investors (6.82M shares), BlackRock Inc. (6.75M shares), VANGUARD GROUP INC (6.55M shares), Champlain Investment Partners, LLC (5.59M shares), Eaton Vance Management (4.22M shares), JANUS HENDERSON GROUP PLC (3.28M shares), Clearbridge Investments, LLC (2.55M shares), COOKE & BIELER LP (2.53M shares), and ALLIANCEBERNSTEIN L.P. (2.28M shares).
This table shows the top 263 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.